The Pharmaceutical Market: Chile

Date: January 31, 2013
Pages: 141
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PD4DC281C72EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Chile
OVERVIEW OF THE PHARMACEUTICAL MARKET IN CHILE

Pharmaceutical companies will continue to look to fast growing emerging markets for revenue growth, and we believe that Latin American economies, with rising incomes, ageing populations and increased spending on healthcare will provide significant opportunities. Indeed, it is our view that emerging markets will be the main drivers of the pharmaceutical sector's expansion over the coming years as growth in traditional markets such as the US, Western Europe and Japan remains lacklustre. We note however, that imported patented and high-cost drugs, mostly originating from Europe and the US, account for a significant portion of the Latin American pharmaceutical market in terms of value.

Headline Expenditure Projections

Pharmaceuticals: CLP1,508bn (US$3.12bn) in 2011 to CLP1,642bn (US$3.22bn) in 2012; +8.9% in local currency terms and +3.3% in US dollar terms.

Healthcare: CLP9,034bn (US$18.67bn) in 2011 to CLP9,941bn (US$19.49bn) in 2012; +10.0% in local currency terms and +4.4% in US dollar terms.

Medical devices: CLP256.33bn (US$530mn) in 2011 to CLP267.45bn (US$525mn) in 2012; +4.3% in local currency terms and -1.0% in US dollar terms.

Risk/Reward Rating: In Q4 12's America's pharmaceutical risk / reward ratings (RRRs) matrix, Chile ranks in seventh place out of the 17 countries surveyed, scoring a total of 53.7 out of 100. We expect Chile, which has a favourable rewards profile, to climb up the regional matrix over the coming years as operational risks become addressed. In the Q412 RRRs, with regards to the country's attractiveness to innovative drug companies, Chile stands above Argentina and Peru and below Mexico and Brazil.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI INDUSTRY VIEW

SWOT

INDUSTRY FORECAST

PHARMACEUTICAL MARKET FORECAST

   Table: Table: Pharmaceutical Sales Indicators 2008-2016

HEALTHCARE MARKET FORECAST

   Table: Table: Healthcare Expenditure Indicators 2009-2017
   Table: Table: Healthcare Governmental Indicators 2009-2017
   Table: Table: Healthcare Private Indicators 2009-2017

ECONOMIC ANALYSIS

   Table: CHILE - ECONOMIC ACTIVITY

INDUSTRY FORECAST - PRESCRIPTION

   Table: Table: Prescription Drug Sales Indicators 2008-2016

INDUSTRY FORECAST PATENTED DRUG MARKET FORECAST

   Table: Table: Patented Drug Market Indicators 2008-2016

GENERICS FORECAST

   Table: Table: Generic Drug Sales Indicators 2009-2017

INDUSTRY FORECAST OTC

   Table: Table: OTC Medicine Sales Indicators 2009-2017

INDUSTRY FORECAST IMPORT/EXPORT

   Table: Exports And Imports Indicators 2009-2017
   Table: ASILFA's Members, 2010
   Table: CANALAB's Members, 2008
   Table: CIF's Members, 2010

INDUSTRY FORECAST MEDICAL DEVICES

   Table: Medical Devices Sales Indicators 2009-2017

INDUSTRY FORECAST OTHER HEALTHCARE DATA

INDUSTRY RISK REWARD RATINGS

   Table: Table: Americas Pharmaceutical Risk/Reward Ratings, Q412

MARKET OVERVIEW

INDUSTRY TRENDS AND DEVELOPMENTS

   Epidemiology
  Healthcare Sector
   Table: Isapres Beneficiaries, 1990-2009
   Table: Beneficiaries by Isapre Type, 2009
   Table: Major Structural Implementations, 2000-2010
   Table: The Five-Law Reform Bill
   Table: Isapres' Solvency Bill
  Healthcare Sector Developments
   Table: Physicians by Specialty, 2000-2009
  Healthcare Insurance
  Research And Development
  Medical Devices

REGULATORY DEVELOPMENT

   Table: CORFO's INNOVA Chile's Biotechnology Manufacturers, 2007
   Table: Table: Latin American Regulations On Bioequivalence And GMP
   Table: List of Therapeutically Equivalent Pharmaceuticals, 15th July 2010
  Intellectual Property Issues
  Trade Agreements
  Pricing Regime
   Table: Table: Pharmaceutical Price Build-Up (%)
  Reimbursement Regime

COMPETITIVE LANDSCAPE

  Pharmaceutical Sector
  Domestic Industry
  Foreign Industry
  Pharmaceutical Distribution
   Table: SOCOFAR's Sales, 2002-2008 (COPmn)
  Pharmaceutical Retail Sector
   Table: Pharmacies by Leading Pharmacy Chain, 2003-2009
   Table: Farmacias Ahumada's Sales in Chile, 2002-2008 (COPmn)
   Table: Farmacias Cruz Verde's Sales, 2002-2008 (Million Pesos)
   Table: Pharmacy Sales Value by Sector, 2007-2008 (US$mn)
   Table: Pharmacy Sales Volume by Sector, 2007-2008 (Million Units)
   Table: Summary of Pharmaceutical Establishments & Workforce, 2000-2007
   Table: Pharmaceutical Establishments & Workforce by Company Size, 2000-2007
   Table: Summary of Pharmaceutical Production, 2000-2007 (COPmn)
   Table: Summary of Pharmaceutical Production, 2000-2007 (US$mn)
   Table: Pharmaceutical Production by Establishment Size, 2000-2007 (Million Pesos)

COMPANY PROFILE

LABORATORIOS CHILE (LABCHILE)

CORPORACIÓN FARMACÉUTICA RECALCINE (CFR)

LABORATORIOS ANDRÓMACO

PFIZER

NOVARTIS

SANOFI

GLAXOSMITHKLINE

MERCK & CO.

OTHER COMPANY DEVELOPMENTS

   Table: Andrómaco's Workforce by Subsidiary, 2009
   Table: Andrómaco's Sales, 2002-2009 (Million Pesos)

DEMOGRAPHIC FORECAST

DEMOGRAPHIC FORECAST

   Table: Chile's Population By Age Group, 1990-2020 ('000)
   Table: Chile's Population By Age Group, 1990-2020 (% of total)
   Table: Chile's Key Population Ratios, 1990-2020
   Table: Chile's Rural And Urban Population, 1990-2020

GLOSSARY

METHODOLOGY

  Risk/Reward Ratings Methodology
  Ratings Overview
   Table: Pharmaceutical Business Environment Indicators
  Weighting
   Table: Weighting Of Components
  Sources
Skip to top


The Pharmaceutical Market: Croatia US$ 1,295.00 Jan, 2013 · 86 pages
The Pharmaceutical Market: Cuba US$ 1,295.00 Mar, 2013
The Pharmaceutical Market: Czech Republic US$ 1,295.00 Jan, 2013 · 90 pages
The Pharmaceutical Market: Denmark US$ 1,295.00 Mar, 2013
The Pharmaceutical Market: Egypt US$ 1,295.00 Jan, 2013 · 111 pages

Ask Your Question

The Pharmaceutical Market: Chile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: